Author:
Chen John Z.,Finlay Warren H.,Martin Andrew
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Organic Chemistry,Pharmaceutical Science,Pharmacology,Molecular Medicine,Biotechnology
Reference36 articles.
1. Pharmacopiea U. Aerosols, nasal sprays, metered-dose inhalers, and dry powder inhalers. US Pharmacopeial [Internet]. 2006;30:2617–36. Available from: http://www.pharmacopeia.cn/v29240/usp29nf24s0_c601_viewall.html
2. U.S. Department of Health and Human Services, Food and Drug Administration Center for Drug Evaluation and Research D of DI (HFD-240). Draft: Guidance for Industry Bioavailability and Bioequivalence Studies for Nasal Aerosol and Nasal Sprays for Local Action. 2003; Available from: http://www.fda.gov/cder/guidance/index.htm
3. Newman SP, Pitcairn GR, Dalby RN. Drug Delivery to the Nasal Cavity: In Vitro and In Vivo Assessment. Critical Reviews in Therapeutic Drug Carrier Systems. 2004;21:46.
4. Li Bv, Jin F, Lee SL, Bai T, Chowdhury, Badrul Caramenico HT, Conner DP. Bioequivalence for locally acting nasal spray and nasal aerosol products: Standard development and generic approval. The AAPS Journal. 2013;15:875–83.
5. Below A, Bickmann D, Breitkreutz J. Assessing the performance of two dry powder inhalers in preschool children using an idealized pediatric upper airway model. International Journal of Pharmaceutics. Elsevier B.V.; 2013;444:169–74.
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献